Vectura is a FTSE 250, industry-leading device & formulation business for inhaled airways disease.
Horizon Discovery is a world-leader in the application of gene editing and gene modulation technologies and is at the centre of innovation and drug discovery.
IBA is a global leader in proton therapy solutions for the treatment of cancer.
Arix Bioscience is focused on generating value from innovation in healthcare, with a permanent capital structure supporting a long-term investment model.
Immunocore is the world’s leading TCR (T cell receptor) company focused on delivering first-in-class biologics that transform lives. The Company’s therapeutics have broad applicability across a wide range of indications, including solid tumours and infectious diseases, and can access a far wider range of targets than typical antibody-based therapies. Its ImmTAC technology enables circulating T cells to selectively identify and kill diseased cells with ultra-high specificity and potency and reduced toxicity.
Quanta is a medical device company providing innovative haemodialysis solutions for the clinic and the home.